Westhampton Capital
TMO icon

Westhampton Capital’s Thermo Fisher Scientific TMO Stock Holding History

Westhampton Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.72M Hold
2,551
– – 0.76% 32
2026
Q2 		$1.28M Buy
2,551
+63
+3% +$30.2K 0.53% 54
2026
Q1 		$1.22M Hold
2,488
– – 0.57% 53
2025
Q4 		$1.44M Buy
2,488
+30
+1% +$17K 0.68% 48
2025
Q3 		$1.19M Buy
2,458
+45
+2% +$20.9K 0.58% 51
2025
Q2 		$978K Buy
2,413
+168
+7% +$70.2K 0.51% 62
2025
Q1 		$1.12M Sell
2,245
-47
-2% -$25.5K 0.61% 56
2024
Q4 		$1.19M Buy
2,292
+75
+3% +$41.2K 0.61% 55
2024
Q3 		$1.37M Buy
2,217
+30
+1% +$17.8K 0.7% 51
2024
Q2 		$1.21M Hold
2,187
– – 0.66% 49
2024
Q1 		$1.27M Sell
2,187
-30
-1% -$16.8K 0.69% 50
2023
Q4 		$1.18M Buy
2,217
+60
+3% +$29K 0.7% 50
2023
Q3 		$1.09M Buy
2,157
+170
+9% +$90.6K 0.7% 50
2023
Q2 		$1.04M Hold
1,987
– – 0.67% 51
2023
Q1 		$1.15M Hold
1,987
– – 0.74% 48
2022
Q4 		$1.09M Hold
1,987
– – 0.74% 51
2022
Q3 		$1.01M Hold
1,987
– – 0.76% 49
2022
Q2 		$1.08M Buy
1,987
+62
+3% +$34.1K 0.76% 47
2022
Q1 		$1.14M Hold
1,925
– – 0.73% 46
2021
Q4 		$1.28M Hold
1,925
– – 0.79% 44
2021
Q3 		$1.1M Hold
1,925
– – 0.75% 46
2021
Q2 		$971K Buy
1,925
+200
+12% +$94.4K 0.63% 52
2021
Q1 		$787K Sell
1,725
-25
-1% -$11.9K 0.54% 59
2020
Q4 		$815K Hold
1,750
– – 0.61% 52
2020
Q3 		$773K Hold
1,750
– – 0.63% 49
2020
Q2 		$634K Sell
1,750
-100
-5% -$33.5K 0.55% 53
2020
Q1 		$525K Buy
1,850
+100
+6% +$31.5K 0.55% 55
2019
Q4 		$569K Hold
1,750
– – 0.46% 63
2019
Q3 		$510K Hold
1,750
– – 0.43% 64
2019
Q2 		$514K Buy
+1,750
New +$482K 0.43% 65

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Westhampton Capital's TMO Position: Q3 2026 in Review

Westhampton Capital held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 2,551 shares worth $1.72M. The position accounts for 0.76% of the portfolio, ranked #32.

Westhampton Capital first reported a position in TMO in Q2 2019 and has held it in 30 quarters since. 1,167 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Westhampton Capital held 2,551 shares of Thermo Fisher Scientific worth $1.72M as of Q3 2026.
  • Westhampton Capital left its Thermo Fisher Scientific share count unchanged in Q3 2026.
  • Thermo Fisher Scientific made up 0.76% of Westhampton Capital's portfolio in Q3 2026, its #32 holding.
  • Westhampton Capital first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 30 quarters since.
  • 1,167 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Westhampton Capital's 13F filing for Q3 2026, filed 30 Oct 2026.